| Haleon Plc (HLN) | |||
|---|---|---|---|
| 9.39 0 (0%) | 01-24 16:00 | ||
| Open: | 9.39 | Pre. Close: | 9.39 |
| High: | 9.43 | Low: | 9.38 |
| Volume: | 5,950,701 | Market Cap: | 42,506(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 11.14 One year: 11.62 |
| Support: | Support1: 8.86 Support2: 7.37 |
| Resistance: | Resistance1: 9.53 Resistance2: 9.95 |
| Pivot: | 9.29  |
| Moving Averages: | MA(5): 9.30  MA(20): 9.37 MA(100): 9.86 MA(250): 9.11 |
| MACD: | MACD(12,26): -0.10 Signal(12,26,9): -0.11 |
| %K %D: | %K(14,3): 64.79 %D(3): 55.18 |
| RSI: | RSI(14): 48.96 |
| 52-Week: | High: 10.8 Low: 7.89 Change(%): 16.2 |
| Average Vol(K): | 3-Month: 7729 10-Days: 13038 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 9.442 - 9.488 | 9.488 - 9.533 |
| Low: | 9.242 - 9.301 | 9.301 - 9.359 |
| Close: | 9.282 - 9.374 | 9.374 - 9.466 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HLN ] has closed below upper band by 33.4%. Bollinger Bands are 6.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Company profile |
|---|
| Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Thu, 23 Jan 2025 Haleon (LON:HLN) Hits New 52-Week High - Time to Buy? - MarketBeat Wed, 22 Jan 2025 Haleon rises Wednesday, outperforms market - MarketWatch Wed, 22 Jan 2025 Morgan Stanley cuts Haleon stock price target to $10.05 - Investing.com Wed, 22 Jan 2025 Jefferies maintains Buy on Haleon stock, target at GBP4.50 - MSN Tue, 21 Jan 2025 Haleon falls Tuesday, underperforms market - MarketWatch Tue, 21 Jan 2025 Ritholtz Wealth Management Purchases 33,249 Shares of Haleon plc (NYSE:HLN) - MarketBeat |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty & Generic | |
| Shares Out. (M) | 4520.00 |
| Shares Float (M) | 7740.00 |
| % Held by Insiders | 4.37 |
| % Held by Institutions | 11.54 |
| Shares Short (K) | 16990 |
| Shares Short Prior Month (K) | 11740 |
| Stock Financials | |
|---|---|
| EPS | 0.320 |
| Book Value (p.s.) | 1.820 |
| Profit Margin | 10.75 |
| Operating Margin | 25.36 |
| Return on Assets (ttm) | |
| Return on Equity (ttm) | |
| Qtrly Rev. Growth | -0.6 |
| Gross Profit (p.s.) | |
| Sales Per Share | 2.487 |
| EBITDA (p.s.) | 0.595 |
| Qtrly Earnings Growth | 34.80 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | |
| Stock Valuation | |
|---|---|
| PE Ratio | 29.34 |
| PEG Ratio | |
| Price to Book value | 5.16 |
| Price to Sales | 3.78 |
| Price to Cash Flow | |
| Stock Dividends | |
|---|---|
| Dividend | 0.050 |
| Dividend Yield | 0.01 |
| Dividend Growth | |
